Genmab A/S (GMABN) Ratios
0 Followers
Genmab A/S Ratios
MX:GMABN's free cash flow for Q2 2026 was kr48.00M. For the 2026 fiscal year, MX:GMABN's free cash flow was decreased by kr-3.00M and operating cash flow was kr51.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.02 | 5.25 | 13.34 | 15.48 | 14.50 |
| Quick Ratio | 2.01 | 5.24 | 13.32 | 15.48 | 14.50 |
| Cash Ratio | 1.20 | 1.86 | 5.99 | 5.43 | 5.71 |
| Solvency Ratio | 0.15 | 0.91 | 1.27 | 2.05 | 1.32 |
| Operating Cash Flow Ratio | 0.86 | 1.46 | 2.97 | 2.15 | 1.42 |
| Short-Term Operating Cash Flow Coverage | 4.24 | 84.47 | 82.00 | 52.86 | 35.94 |
| Net Current Asset Value | kr -4.13B | kr 18.74B | kr 29.46B | kr 25.38B | kr 20.30B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.43 | 0.02 | 0.02 | 0.02 | 0.02 |
| Debt-to-Equity Ratio | 0.95 | 0.03 | 0.02 | 0.02 | 0.02 |
| Debt-to-Capital Ratio | 0.49 | 0.03 | 0.02 | 0.02 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.47 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.20 | 1.25 | 1.12 | 1.10 | 1.11 |
| Debt Service Coverage Ratio | 3.16 | 39.51 | 40.22 | 61.42 | 42.72 |
| Interest Coverage Ratio | 20.49 | 58.36 | 197.07 | 298.43 | 227.15 |
| Debt to Market Cap | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 90.28 | 17.78 | 12.20 | 9.45 | 6.70 |
| Net Debt to EBITDA | 2.80 | -0.91 | -2.35 | -1.27 | -2.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 91.69% | 95.42% | 98.63% | 100.00% | 100.00% |
| EBIT Margin | 33.60% | 32.53% | 34.38% | 47.73% | 47.11% |
| EBITDA Margin | 35.44% | 45.05% | 36.37% | 50.21% | 49.27% |
| Operating Profit Margin | 33.60% | 32.53% | 32.30% | 42.94% | 34.81% |
| Pretax Profit Margin | 32.37% | 42.57% | 34.22% | 47.58% | 46.96% |
| Net Profit Margin | 25.89% | 36.44% | 26.42% | 37.36% | 34.86% |
| Continuous Operations Profit Margin | 25.89% | 36.44% | 26.42% | 37.36% | 35.46% |
| Net Income Per EBT | 79.98% | 85.60% | 77.20% | 78.50% | 74.24% |
| EBT Per EBIT | 96.32% | 130.86% | 105.94% | 110.82% | 134.88% |
| Return on Assets (ROA) | 7.78% | 17.12% | 12.33% | 18.10% | 12.01% |
| Return on Equity (ROE) | 17.13% | 21.38% | 13.77% | 19.98% | 13.32% |
| Return on Capital Employed (ROCE) | 11.36% | 17.29% | 16.22% | 22.15% | 12.81% |
| Return on Invested Capital (ROIC) | 8.86% | 14.77% | 12.49% | 17.34% | 9.65% |
| Return on Tangible Assets | 29.50% | 25.36% | 12.37% | 18.19% | 12.13% |
| Earnings Yield | 0.79% | 8.13% | 3.09% | 2.84% | 1.72% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.36 | 3.22 | 3.33 | 2.48 | 2.50 |
| Payables Turnover | 0.30 | 0.28 | 0.10 | 0.00 | 0.00 |
| Inventory Turnover | 17.85 | 15.89 | 3.96 | 0.00 | 0.00 |
| Fixed Asset Turnover | 13.82 | 11.38 | 10.04 | 11.04 | 8.70 |
| Asset Turnover | 0.30 | 0.47 | 0.47 | 0.48 | 0.34 |
| Working Capital Turnover Ratio | 0.32 | 0.81 | 0.58 | 0.61 | 0.44 |
| Cash Conversion Cycle | -1085.20 | -1153.86 | -3524.24 | 147.40 | 146.22 |
| Days of Sales Outstanding | 108.70 | 113.45 | 109.61 | 147.40 | 146.22 |
| Days of Inventory Outstanding | 20.45 | 22.97 | 92.06 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1214.35 | 1290.28 | 3725.91 | 0.00 | 0.00 |
| Operating Cycle | 129.15 | 136.43 | 201.66 | 147.40 | 146.22 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 19.80 | 120.23 | 113.00 | 59.83 | 34.07 |
| Free Cash Flow Per Share | 19.18 | 117.34 | 107.24 | 54.98 | 30.22 |
| Dividend Paid and CapEx Coverage Ratio | 32.05 | 41.56 | 19.63 | 12.34 | 8.84 |
| Capital Expenditure Coverage Ratio | 32.05 | 41.56 | 19.63 | 12.34 | 8.84 |
| Operating Cash Flow Coverage Ratio | 0.22 | 7.55 | 9.58 | 6.55 | 5.24 |
| Operating Cash Flow to Sales Ratio | 0.32 | 0.36 | 0.45 | 0.27 | 0.26 |
| Free Cash Flow Yield | 0.95% | 7.86% | 4.98% | 1.87% | 1.15% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 126.06 | 12.21 | 32.34 | 35.27 | 58.16 |
| Price-to-Sales (P/S) Ratio | 32.64 | 4.48 | 8.54 | 13.18 | 20.28 |
| Price-to-Book (P/B) Ratio | 21.59 | 2.63 | 4.45 | 7.05 | 7.75 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 105.67 | 12.72 | 20.09 | 53.49 | 87.04 |
| Price-to-Operating Cash Flow Ratio | 102.38 | 12.41 | 19.07 | 49.16 | 77.20 |
| Price-to-Earnings Growth (PEG) Ratio | -1.45 | 0.15 | -1.61 | 0.43 | -1.57 |
| Enterprise Value Multiple | 94.90 | 9.04 | 21.14 | 24.97 | 39.11 |
| Enterprise Value | 129.82B | 87.64B | 126.65B | 183.01B | 163.46B |
| EV to EBITDA | 94.90 | 9.04 | 21.14 | 24.97 | 39.11 |
| EV to Sales | 33.63 | 4.07 | 7.69 | 12.54 | 19.27 |
| EV to Free Cash Flow | 108.89 | 11.56 | 18.08 | 50.91 | 82.72 |
| EV to Operating Cash Flow | 105.49 | 11.28 | 17.16 | 46.78 | 73.37 |
| Tangible Book Value Per Share | -58.29 | 337.58 | 482.45 | 415.01 | 335.53 |
| Shareholders’ Equity Per Share | 93.87 | 567.77 | 484.00 | 417.24 | 339.41 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.14 | 0.23 | 0.21 | 0.24 |
| Revenue Per Share | 62.10 | 333.05 | 252.24 | 223.21 | 129.70 |
| Net Income Per Share | 16.08 | 121.36 | 66.64 | 83.38 | 45.22 |
| Tax Burden | 0.80 | 0.86 | 0.77 | 0.79 | 0.74 |
| Interest Burden | 0.96 | 1.31 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.42 | 0.45 | 0.46 | 0.38 | 0.49 |
| SG&A to Revenue | 0.16 | 0.18 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.04 | 0.03 | 0.04 |
| Income Quality | 1.23 | 0.99 | 1.31 | 0.56 | 0.56 |
Currency in DKK
